Iradimed (IRMD) FCF Margin Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 38.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 30.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 943.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 96.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -2,196.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -20.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 2,679.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -461.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 417.00 |
| 10 | Iradimed | 1.17 Bn | 1.11 Bn | 16.81 Mn | 4,719.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4,719.00 |
| Dec 31, 2025 | 3,712.00 |
| Sep 30, 2025 | 169.00 |
| Jun 30, 2025 | 1,364.00 |
| Mar 31, 2025 | -705.00 |
| Dec 31, 2024 | -1,298.00 |
| Sep 30, 2024 | -643.00 |
| Jun 30, 2024 | 133.00 |
| Mar 31, 2024 | 1,174.00 |
| Dec 31, 2023 | -919.00 |
| Sep 30, 2023 | -905.00 |
| Jun 30, 2023 | 4,970.00 |
| Mar 31, 2023 | -2,318.00 |
| Dec 31, 2022 | -1,797.00 |
| Sep 30, 2022 | -483.00 |
| Jun 30, 2022 | -1,430.00 |
| Mar 31, 2022 | 233.00 |
| Dec 31, 2021 | -1,439.00 |
| Sep 30, 2021 | 2,192.00 |
| Jun 30, 2021 | 1,475.00 |
| Mar 31, 2021 | -1,349.00 |
| Dec 31, 2020 | 2,127.00 |
| Sep 30, 2020 | -1,649.00 |
| Jun 30, 2020 | 455.00 |
| Mar 31, 2020 | 1,545.00 |
| Dec 31, 2019 | 376.00 |
| Sep 30, 2019 | -1,412.00 |
| Jun 30, 2019 | 1,504.00 |
| Mar 31, 2019 | -1,613.00 |
| Dec 31, 2018 | 1,792.00 |
| Sep 30, 2018 | -2,225.00 |
| Jun 30, 2018 | -51.00 |
| Mar 31, 2018 | 775.00 |
| Dec 31, 2017 | 3,713.00 |
| Sep 30, 2017 | 1,344.00 |
| Jun 30, 2017 | -3,259.00 |
| Mar 31, 2017 | -1,645.00 |
| Dec 31, 2016 | 1,223.00 |
| Sep 30, 2016 | 4,073.00 |